Request for Nominations of Candidates To Serve on the Board of Scientific Counselors (BSC), Office of Infectious Diseases (OID), 58353-58354 [2014-23055]
Download as PDF
<![CDATA[
Federal Register / Vol. 79, No. 188 / Monday, September 29, 2014 / Notices
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Notice of issuance of 10 Final
Skin Notation Profile publications
ACTION:
Prevention and the Agency for Toxic
Substances and Disease Registry.
Centers for Disease Control and
Prevention
(NIOSH) of the Centers for Disease
Control and Prevention (CDC),
Department of Health and Human
Services (HHS).
Claudette Grant,
Acting Director, Management Analysis and
Services Office, Centers for Disease Control
and Prevention.
SUMMARY:
Advisory Committee to the Director
(ACD), Centers for Disease Control and
Prevention (CDC)
Substance(s)
In accordance with section 10(a)(2) of
the Federal Advisory Committee Act
(Pub. L. 92–463), the Centers for Disease
Control and Prevention (CDC)
announces the following meeting of the
aforementioned committee:
The National Institute for
Occupational Safety and Health
(NIOSH) of the Centers for Disease
Control and Prevention (CDC)
announces the availability of the
following 10 Skin Notation Profiles:
Allyl glycidyl ether: https://
www.cdc.gov/niosh/docs/2014-143/
pdfs/2014-143.pdf.
2-Diethylaminoethanol: https://
www.cdc.gov/niosh/docs/2014-140/
pdfs/2014-140.pdf.
2-Ethoxyethyl acetate: https://
www.cdc.gov/niosh/docs/2014-141/
pdfs/2014-141.pdf.
Ethyl acrylate: https://www.cdc.gov/
niosh/docs/2014-144/pdfs/2014144.pdf.
Isophorone diisocyanate: https://
www.cdc.gov/niosh/docs/2014-144/
pdfs/2014-144.pdf.
2-Mercaptobenzothiazole (MBT);
Sodium 2–MBT; Zinc 2–MBT: https://
www.cdc.gov/niosh/docs/2014-142/
pdfs/2014-142.pdf.
Methyl isocyanate: https://
www.cdc.gov/niosh/docs/2014-145/
pdfs/2014-145.pdf.
Nitrobenzene: https://www.cdc.gov/
niosh/docs/2014-146/pdfs/2014146.pdf.
Phenylhydrazine: https://
www.cdc.gov/niosh/docs/2014-147/
pdfs/2014-147.pdf.
Propargyl alcohol: https://
www.cdc.gov/niosh/docs/2014-149/
pdfs/2014-149.pdf.
These documents are
available at the following Web site:
https://www.cdc.gov/niosh/topics/skin/
skin-notation_profiles.html
ADDRESSES:
FOR FURTHER INFORMATION CONTACT:
tkelley on DSK3SPTVN1PROD with NOTICES
Naomi Hudson, Dr.P.H.: NIOSH, 1090
Tusculum Ave., MS–C32, Cincinnati,
OH 45226, Telephone: (513) 533–8540,
email: iuz8@cdc.gov.
Dated: September 22, 2014.
John Howard,
Director, National Institute for Occupational
Safety and Health, Centers for Disease Control
and Prevention.
[FR Doc. 2014–23086 Filed 9–26–14; 8:45 am]
BILLING CODE 4163–19–P
VerDate Sep<11>2014
16:44 Sep 26, 2014
Jkt 232001
58353
Time and Date: 8:30 a.m.–3:00 p.m. (EDT),
October 23, 2014.
Place: CDC, Building 21, Rooms 1204 A/B,
1600 Clifton Road NE., Atlanta, Georgia
30333
Status: Open to the public, limited only by
the space and phone lines available. The
meeting room accommodates approximately
50 people. (Advance registration for inperson participation is required by October
16, 2014.) The public is welcome to
participate during the public comment
period, which is tentatively scheduled from
2:40 p.m. to 2:45 p.m. This meeting will also
be available by:
Teleconference: Please dial (877) 930–8819
and enter code 1579739.
Web links: Windows Media: (Closed
captioning will be available) https://
wm.onlinevideoservice.com/CDC1
Flash: https://www.onlinevideoservice.com/
clients/CDC/?mount=CDC3.
If you are unable to connect using the link,
copy and paste the link into your Web
browser. For technical support please call:
(404) 639–3737.
Purpose: The committee will provide
advice to the CDC Director on strategic and
other broad issues facing CDC.
Matters for Discussion: The Advisory
Committee to the Director will receive
updates from the State, Tribal, Local and
Territorial Subcommittee; the Health
Disparities Subcommittee, the Global
Workgroup, the Internal and External
Laboratory Safety Workgroups, and the
Public Health—Health Care Collaboration
Workgroup, the Ebola response, as well as an
update from the CDC Director. Agenda items
are subject to change as priorities dictate.
For More Information Contact: Carmen
Villar, MSW, Designated Federal Officer,
ACD, CDC, 1600 Clifton Road, NE., M/S D–
14, Atlanta, Georgia 30333. Telephone (404)
639–7158, Email: GHickman@cdc.gov. The
deadline to register for in-person attendance
at this meeting is October 16, 2014. To
register, please send an email to GHickman@
cdc.gov.
The Director, Management Analysis and
Services Office, has been delegated the
authority to sign Federal Register notices
pertaining to announcements of meetings and
other committee management activities, for
both the Centers for Disease Control and
PO 00000
Frm 00041
Fmt 4703
Sfmt 4703
[FR Doc. 2014–23054 Filed 9–26–14; 8:45 am]
BILLING CODE 4163–18–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Centers for Disease Control and
Prevention
Request for Nominations of
Candidates To Serve on the Board of
Scientific Counselors (BSC), Office of
Infectious Diseases (OID)
The Centers for Disease Control and
Prevention (CDC) is soliciting
nominations for possible membership
on the BSC, OID. This board consists of
17 experts in fields related to infectious
diseases who are selected by the
Secretary of the U.S. Department of
Health and Human Services (HHS). The
board advises the HHS Secretary; the
CDC Director; the OID Director; and the
Directors of the National Center for
Immunization and Respiratory Diseases
(NCIRD), the National Center for
Emerging and Zoonotic Infectious
Diseases (NCEZID), and the National
Center for HIV/AIDS, Viral Hepatitis,
STD, and TB Prevention (NCHHSTP)
concerning strategies, goals, and
priorities for the programs and research
within the national centers; and
monitors the overall strategic direction
and focus of OID and the national
centers.
Nominations are being sought for
individuals who have expertise and
qualifications necessary to contribute to
the accomplishment of the board’s
mission. Nominees will be selected by
the HHS Secretary or designee from
authorities knowledgeable in the fields
of infectious diseases and related
disciplines, including epidemiology,
microbiology, bacteriology, virology,
pathogen genomics, bioinformatics,
clinical medicine, and veterinary
medicine, as well as from the general
public. Members may be invited to serve
for terms of up to four years.
The U.S. Department of Health and
Human Services policy stipulates that
committee membership shall be
balanced in terms of professional
training and background, points of view
represented, and the committee’s
function. In addition to a broad range of
expertise, consideration is given to a
broad representation of geographic areas
within the U.S., with diverse
E:\FR\FM\29SEN1.SGM
29SEN1
58354
Federal Register / Vol. 79, No. 188 / Monday, September 29, 2014 / Notices
representation of both genders, ethnic
and racial minorities, and persons with
disabilities. Nominees must be U.S.
citizens, and cannot be full-time
employees of the U.S. Government.
Candidates should submit the
following items:
• Current curriculum vitae, including
complete contact information (name,
affiliation, mailing address, telephone
number, email address)
• A letter of recommendation stating
the qualifications of the candidate
Nomination materials must be
postmarked by October 24, 2014, and
sent to: Kim Distel, Office of Infectious
Diseases, Centers for Disease Control
and Prevention, 1600 Clifton Road NE.,
Mailstop D10, Atlanta, Georgia 30333,
telephone (404) 639–2100.
The Director, Management Analysis
and Services Office, has been delegated
the authority to sign Federal Register
notices pertaining to announcements of
meetings and other committee
management activities for both the
Centers for Disease Control and
Prevention, and the Agency for Toxic
Substances and Disease Registry.
Claudette Grant,
Acting Director, Management Analysis and
Services Office, Centers for Disease Control
and Prevention.
[FR Doc. 2014–23055 Filed 9–26–14; 8:45 am]
BILLING CODE 4163–18–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Centers for Medicare & Medicaid
Services
[Document Identifiers: CMS–10492]
Agency Information Collection
Activities: Proposed Collection;
Comment Request
Centers for Medicare &
Medicaid Services.
ACTION: Notice.
AGENCY:
The Centers for Medicare &
Medicaid Services (CMS) is announcing
an opportunity for the public to
comment on CMS’ intention to collect
information from the public. Under the
Paperwork Reduction Act of 1995 (the
PRA), federal agencies are required to
publish notice in the Federal Register
concerning each proposed collection of
information (including each proposed
extension or reinstatement of an existing
collection of information) and to allow
60 days for public comment on the
proposed action. Interested persons are
invited to send comments regarding our
burden estimates or any other aspect of
tkelley on DSK3SPTVN1PROD with NOTICES
SUMMARY:
VerDate Sep<11>2014
16:44 Sep 26, 2014
Jkt 232001
this collection of information, including
any of the following subjects: (1) The
necessity and utility of the proposed
information collection for the proper
performance of the agency’s functions;
(2) the accuracy of the estimated
burden; (3) ways to enhance the quality,
utility, and clarity of the information to
be collected; and (4) the use of
automated collection techniques or
other forms of information technology to
minimize the information collection
burden.
Comments must be received by
November 28, 2014:
ADDRESSES: When commenting, please
reference the document identifier or
OMB control number (OCN). To be
assured consideration, comments and
recommendations must be submitted in
any one of the following ways:
1. Electronically. You may send your
comments electronically to https://
www.regulations.gov. Follow the
instructions for ‘‘Comment or
Submission’’ or ‘‘More Search Options’’
to find the information collection
document(s) that are accepting
comments.
2. By regular mail. You may mail
written comments to the following
address:
CMS, Office of Strategic Operations and
Regulatory Affairs, Division of
Regulations Development,
Attention: Document Identifier/
OMB Control Number _________,
Room C4–26–05, 7500 Security
Boulevard, Baltimore, Maryland
21244–1850.
To obtain copies of a supporting
statement and any related forms for the
proposed collection(s) summarized in
this notice, you may make your request
using one of following:
1. Access CMS’ Web site address at
https://www.cms.hhs.gov/
PaperworkReductionActof1995.
2. Email your request, including your
address, phone number, OMB number,
and CMS document identifier, to
Paperwork@cms.hhs.gov.
3. Call the Reports Clearance Office at
(410) 786–1326.
FOR FURTHER INFORMATION CONTACT:
Reports Clearance Office at (410) 786–
1326.
DATES:
SUPPLEMENTARY INFORMATION:
Contents
This notice sets out a summary of the
use and burden associated with the
following information collections. More
detailed information can be found in
each collection’s supporting statement
and associated materials (see
ADDRESSES). CMS–10492 Data
PO 00000
Frm 00042
Fmt 4703
Sfmt 4703
Submission for the Federally-faciliated
Exchange User Fee Adjustment
Under the PRA (44 U.S.C. 3501–
3520), federal agencies must obtain
approval from the Office of Management
and Budget (OMB) for each collection of
information they conduct or sponsor.
The term ‘‘collection of information’’ is
defined in 44 U.S.C. 3502(3) and 5 CFR
1320.3(c) and includes agency requests
or requirements that members of the
public submit reports, keep records, or
provide information to a third party.
Section 3506(c)(2)(A) of the PRA
requires federal agencies to publish a
60-day notice in the Federal Register
concerning each proposed collection of
information, including each proposed
extension or reinstatement of an existing
collection of information, before
submitting the collection to OMB for
approval. To comply with this
requirement, CMS is publishing this
notice.
Information Collection
1. Type of Information Collection
Request: New collection (Request for a
new OMB control number); Title of
Information Collection: Data
Submission for the Federally-facilitated
Exchange User Fee Adjustment; Use:
The final rule ‘‘Coverage of Certain
Preventive Services Under the
Affordable Care Act’’ published by the
Departments of Health and Human
Services (HHS), the Treasury, and Labor
on July 2, 2013 (78 FR 39870), sets forth
regulations regarding coverage for
certain preventive services under
section 2713 of the Public Health
Service Act, as added by the Patient
Protection and Affordable Care Act, as
amended, and incorporated into the
Employee Retirement Income Security
Act of 1974 and the Internal Revenue
Code. Section 2713 of the Public Health
Service Act requires coverage without
cost sharing of certain preventive health
services, including certain contraceptive
services, in non-exempt, nongrandfathered group health plans and
health insurance coverage. The final
rules establish accommodations with
respect to group health plans
established or maintained by eligible
organizations (and group health
insurance coverage offered in
connection with such plans). Eligible
organizations are required to self-certify
that they are eligible for this
accommodation and provide a copy of
such self-certification to their third
party administrators. The final rules
also set forth processes and standards to
fund the payments for the contraceptive
services that are provided for
participants and beneficiaries in selfinsured plans of eligible organizations
E:\FR\FM\29SEN1.SGM
29SEN1
]]>Agencies
[Federal Register Volume 79, Number 188 (Monday, September 29, 2014)]
[Notices]
[Pages 58353-58354]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: 2014-23055]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Centers for Disease Control and Prevention
Request for Nominations of Candidates To Serve on the Board of
Scientific Counselors (BSC), Office of Infectious Diseases (OID)
The Centers for Disease Control and Prevention (CDC) is soliciting
nominations for possible membership on the BSC, OID. This board
consists of 17 experts in fields related to infectious diseases who are
selected by the Secretary of the U.S. Department of Health and Human
Services (HHS). The board advises the HHS Secretary; the CDC Director;
the OID Director; and the Directors of the National Center for
Immunization and Respiratory Diseases (NCIRD), the National Center for
Emerging and Zoonotic Infectious Diseases (NCEZID), and the National
Center for HIV/AIDS, Viral Hepatitis, STD, and TB Prevention (NCHHSTP)
concerning strategies, goals, and priorities for the programs and
research within the national centers; and monitors the overall
strategic direction and focus of OID and the national centers.
Nominations are being sought for individuals who have expertise and
qualifications necessary to contribute to the accomplishment of the
board's mission. Nominees will be selected by the HHS Secretary or
designee from authorities knowledgeable in the fields of infectious
diseases and related disciplines, including epidemiology, microbiology,
bacteriology, virology, pathogen genomics, bioinformatics, clinical
medicine, and veterinary medicine, as well as from the general public.
Members may be invited to serve for terms of up to four years.
The U.S. Department of Health and Human Services policy stipulates
that committee membership shall be balanced in terms of professional
training and background, points of view represented, and the
committee's function. In addition to a broad range of expertise,
consideration is given to a broad representation of geographic areas
within the U.S., with diverse
[[Page 58354]]
representation of both genders, ethnic and racial minorities, and
persons with disabilities. Nominees must be U.S. citizens, and cannot
be full-time employees of the U.S. Government.
Candidates should submit the following items:
Current curriculum vitae, including complete contact
information (name, affiliation, mailing address, telephone number,
email address)
A letter of recommendation stating the qualifications of the
candidate
Nomination materials must be postmarked by October 24, 2014, and
sent to: Kim Distel, Office of Infectious Diseases, Centers for Disease
Control and Prevention, 1600 Clifton Road NE., Mailstop D10, Atlanta,
Georgia 30333, telephone (404) 639-2100.
The Director, Management Analysis and Services Office, has been
delegated the authority to sign Federal Register notices pertaining to
announcements of meetings and other committee management activities for
both the Centers for Disease Control and Prevention, and the Agency for
Toxic Substances and Disease Registry.
Claudette Grant,
Acting Director, Management Analysis and Services Office, Centers for
Disease Control and Prevention.
[FR Doc. 2014-23055 Filed 9-26-14; 8:45 am]
BILLING CODE 4163-18-P
